Coronary Artery Bypass Graft Versus Percutaneous Coronary Intervention: Meds Matter Impact of Adherence to Medical Therapy on Comparative Outcomes

Background: Multiple studies have compared coronary artery bypass graft (CABG) with percutaneous coronary interventions (PCI) for coronary revascularization. There is considerable evidence that adherence to medical therapy can affect the outcomes of therapeutic interventions. However, the long-term influence of compliance with recommended medical therapy on the comparative outcomes of CABG versus PCI remains to be defined. Methods: All non–ST-segment–elevation myocardial infarction patients undergoing coronary revascularization in an 8-hospital network were followed for up to 8 years to determine medication history and major adverse cardiac events: all-cause mortality, nonfatal myocardial infarction, and reintervention. All mortalities were checked against the Social Security Death Index. Survival curves were derived with Kaplan-Meier methods; hazard ratios were calculated with the Cox proportional hazard model; and propensity score matching was used to account for differences in patient selection. Results: Among the 973 CABG and 2255 PCI patients, Kaplan-Meier major adverse cardiac event–free survival curves demonstrated a significant benefit for antiplatelet, lipid-lowering, and &bgr;-blocker therapy in both the CABG and PCI groups (P=0.001 for all 3 medications). Cox regression identified compliance with optimal medical therapy as a more powerful predictor of major adverse cardiac event–free survival than choice of therapy (hazard ratio for noncompliance=2.79; 95% confidence limits, 2.19–3.54; P<0.001; hazard ratio for PCI versus CABG=1.68, 95% confidence limits, 138–2.04; P<0.001). In propensity-matched patients, CABG outcomes were superior to PCI outcomes in patients nonadherent to optimal medical therapy (P=0.001) but were not different in patients adherent to optimal medical therapy (P=0.574). Conclusions: Regardless of coronary revascularization strategy, medication adherence has a dramatic effect on long-term outcome. Among comparable patients who adhere to optimal medical therapy, outcomes of PCI and CABG may not differ; however, among nonadherent patients, CABG affords better major adverse cardiac event–free survival. Therefore, patient compliance with medical therapy may inform clinical decision making and should be incorporated into all future comparative studies of comparative coronary revascularization strategies.

[1]  D. Hoffman,et al.  CABG Versus PCI: Greater Benefit in Long-Term Outcomes With Multiple Arterial Bypass Grafting. , 2015, Journal of the American College of Cardiology.

[2]  S. Pocock,et al.  Long-Term Use of Cardiovascular Drugs: Challenges for Research and for Patient Care. , 2015, Journal of the American College of Cardiology.

[3]  Shengshou Hu,et al.  Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery , 2015, Circulation.

[4]  E. Steyerberg,et al.  Optimal Medical Therapy Improves Clinical Outcomes in Patients Undergoing Revascularization With Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting: Insights From the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial at the 5-Year Fol , 2015, Circulation.

[5]  Stacey L. Sheridan,et al.  Quantifying the Utility of Taking Pills for Cardiovascular Prevention , 2015, Circulation. Cardiovascular quality and outcomes.

[6]  J. Vlayen,et al.  Percutaneous coronary invervention versus coronary artery bypass grafting: a meta-analysis. , 2015, The Journal of thoracic and cardiovascular surgery.

[7]  A. Jaffe,et al.  2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[8]  E. Peterson,et al.  Revascularization in stable coronary artery disease. , 2014, JAMA.

[9]  I. Sipahi,et al.  Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era. , 2014, JAMA Internal Medicine.

[10]  E. Tuzcu,et al.  Late Stroke: Comparison of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Multivessel Disease and Unprotected Left Main Disease A Meta-Analysis and Review of Literature , 2014, Stroke.

[11]  H. Wijeysundera,et al.  Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review. , 2013, JAMA.

[12]  A. Raval,et al.  Patient preferences for coronary artery bypass graft surgery or percutaneous intervention in multivessel coronary artery disease , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[13]  M. Mack,et al.  Coronary Artery Revascularization Evaluation—A Multicenter Registry With Seven Years of Follow‐Up , 2013, Journal of the American Heart Association.

[14]  Sankey V. Williams,et al.  2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Ass , 2012, Journal of the American College of Cardiology.

[15]  H. Pfaff,et al.  Physicians' knowledge of and compliance with guidelines: an exploratory study in cardiovascular diseases. , 2011, Deutsches Arzteblatt international.

[16]  Ben A. Williams,et al.  Perils of Evidence-Based Medicine , 2010, Perspectives in biology and medicine.

[17]  P Michael Ho,et al.  Medication Adherence: Its Importance in Cardiovascular Outcomes , 2009, Circulation.

[18]  M. Mack,et al.  Current clinical outcomes of percutaneous coronary intervention and coronary artery bypass grafting. , 2008, The Annals of thoracic surgery.

[19]  A. Lippman Adherence to medication. , 2005, The New England journal of medicine.

[20]  M. J. Cuevas,et al.  Assessment of Adherence to Triple Antiretroviral Treatment Including Indinavir: Role of the Determination of Plasma Levels of Indinavir , 2003, Journal of acquired immune deficiency syndromes.

[21]  N. Maggiano,et al.  Localization of nitric oxide synthase type III in the internal thoracic and radial arteries and the great saphenous vein: a comparative immunohistochemical study. , 2003, The Journal of thoracic and cardiovascular surgery.

[22]  R Brian Haynes,et al.  Helping patients follow prescribed treatment: clinical applications. , 2002, JAMA.

[23]  Muhammad Mamdani,et al.  Adherence with statin therapy in elderly patients with and without acute coronary syndromes. , 2002, JAMA.

[24]  M. Robin DiMatteo,et al.  Patient Adherence and Medical Treatment Outcomes: A Meta-Analysis , 2002, Medical care.

[25]  Sundhiya Mandalia,et al.  Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome , 2002, AIDS.

[26]  M. Chesney,et al.  Patient- and provider-reported adherence: toward a clinically useful approach to measuring antiretroviral adherence. , 2001, Journal of clinical epidemiology.

[27]  S. Kitamura,et al.  Difference in acetylcholine-induced nitric oxide release of arterial and venous grafts in patients after coronary bypass operations. , 1998, The Journal of thoracic and cardiovascular surgery.

[28]  S. Woolf Practice guidelines: a new reality in medicine. III. Impact on patient care. , 1993, Archives of internal medicine.

[29]  M. Enkin,et al.  Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. , 1989, The New England journal of medicine.

[30]  D. Sackett,et al.  Can Simple Clinical Measurements Detect Patient Noncompliance? , 1980, Hypertension.

[31]  G. Lamas,et al.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.